Penicillin Allergy Delabeling Program: an exploratory economic evaluation in the Australian context.
Natasha K BruscoSusan BuryKyra Y L ChuaSara VogrinNatasha E HolmesJason A TrublanoPublished in: Internal medicine journal (2021)
Consistent with international literature, delabeling low-risk penicillin allergies in the inpatient setting had economic advantages in the Australian context. Fully powered economic evaluations are urgently required to consolidate these findings. This article is protected by copyright. All rights reserved.